ACTIVATION OF HIV-1 BY SMOKING AND TUBERCULOSIS

吸烟和结核病激活 HIV-1

基本信息

  • 批准号:
    2460236
  • 负责人:
  • 金额:
    $ 30.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1996
  • 资助国家:
    美国
  • 起止时间:
    1996-09-29 至 2001-07-31
  • 项目状态:
    已结题

项目摘要

In persons infected with human immunodeficiency virus-1 (HIV), the lung is a major target of opportunistic infections and noninfectious complications. Further, recent epidemiologic studies suggest that certain pulmonary infections and irritants, notably pulmonary tuberculosis (TB) and cigarette smoking, increase the rate of progression of HIV disease. The means by which TB and smoking increase HIV progression are, however, unknown. Studies in our laboratory demonstrate that alveolar macrophages (AM) from smokers are several fold more susceptible to HIV infection in vitro that are AM from nonsmokers. The antioxidant N-acetylacysteine and the tumor necrosis factor alpha(TNF) inhibitor pentoxifylline inhibit HIV production in AM from smokers. The cytoplasmic inhibitor of NFkappaB, IkappaB, is decreased and the HIV transcriptional activator, aromatic hydrocarbon receptors (AhR), are activated in AM from smokers. Mycobacterial stimulation of AM from HIV-infected subjects increases transcription of HIV., These and other preliminary data and considerations suggest the hypothesis that transcriptional activation of HIV in AM from smokers and TB patients involves increased reactive oxygen intermediates (R01) and TNF which activate BfkappaB and/or AhR. The Specific Aims are; 1. To elucidate the mechanisms of activation of nFkappaB and AhR for nuclear binding to the HIV LTR in AM from smokers and patients with TB focusing on the roles of R01, TNF, IkappaB, and SAPK. 2. To definitively establish using virologic and molecular approaches the capacity of nFkappaB and AhR to transcriptionally activate HIV in AM from smokers and patients with TB and the underlying mechanisms. 3. To assess the impact of smoking cessation and treatment of TB on the respective pathways activating HIV transcription in AM.
在感染了人类免疫缺陷病毒-1 (HIV)的人,肺是

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ELIZABETH A RICH其他文献

ELIZABETH A RICH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ELIZABETH A RICH', 18)}}的其他基金

The lung in HIV disease
HIV疾病中的肺部
  • 批准号:
    6305453
  • 财政年份:
    1999
  • 资助金额:
    $ 30.6万
  • 项目类别:
PULMONARY PATHOGEN DEFENSE MECHANISMS
肺部病原体防御机制
  • 批准号:
    2430602
  • 财政年份:
    1998
  • 资助金额:
    $ 30.6万
  • 项目类别:
The lung in HIV disease
HIV疾病中的肺部
  • 批准号:
    6115247
  • 财政年份:
    1998
  • 资助金额:
    $ 30.6万
  • 项目类别:
ALVEOLAR MACROPHAGES AND AIDS
肺泡巨噬细胞和艾滋病
  • 批准号:
    6276481
  • 财政年份:
    1997
  • 资助金额:
    $ 30.6万
  • 项目类别:
ALVEOLAR MACROPHAGES AND AIDS
肺泡巨噬细胞和艾滋病
  • 批准号:
    6246402
  • 财政年份:
    1997
  • 资助金额:
    $ 30.6万
  • 项目类别:
ACTIVATION OF HIV-1 BY SMOKING AND TUBERCULOSIS
吸烟和结核病激活 HIV-1
  • 批准号:
    2031156
  • 财政年份:
    1996
  • 资助金额:
    $ 30.6万
  • 项目类别:
NATURAL HISTORY OF LYMPHOCYTIC ALVEOLITIS IN HIV DISEASE
HIV 疾病中淋巴细胞性肺泡炎的自然史
  • 批准号:
    2231076
  • 财政年份:
    1994
  • 资助金额:
    $ 30.6万
  • 项目类别:
NATURAL HISTORY OF LYMPHOCYTIC ALVEOLITIS IN HIV DISEASE
HIV 疾病中淋巴细胞性肺泡炎的自然史
  • 批准号:
    2231077
  • 财政年份:
    1994
  • 资助金额:
    $ 30.6万
  • 项目类别:
NATURAL HISTORY OF LYMPHOCYTIC ALVEOLITIS IN HIV DISEASE
HIV 疾病中淋巴细胞性肺泡炎的自然史
  • 批准号:
    2460085
  • 财政年份:
    1994
  • 资助金额:
    $ 30.6万
  • 项目类别:
NATURAL HISTORY OF LYMPHOCYTIC ALVEOLITIS IN HIV DISEASE
HIV 疾病中淋巴细胞性肺泡炎的自然史
  • 批准号:
    2231075
  • 财政年份:
    1994
  • 资助金额:
    $ 30.6万
  • 项目类别:

相似海外基金

The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
  • 批准号:
    23K08315
  • 财政年份:
    2023
  • 资助金额:
    $ 30.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MICA: Key mechanisms underlying inhaled GM-CSF's enhancement of phagocytosis and bacterial clearance by human alveolar macrophages.
MICA:吸入 GM-CSF 增强人肺泡巨噬细胞吞噬作用和细菌清除的关键机制。
  • 批准号:
    MR/X005046/1
  • 财政年份:
    2023
  • 资助金额:
    $ 30.6万
  • 项目类别:
    Research Grant
Analysis of pathogenic alveolar macrophages which release IL-1alpha in response to fine particles.
分析响应细颗粒物释放 IL-1α 的致病性肺泡巨噬细胞。
  • 批准号:
    23H03154
  • 财政年份:
    2023
  • 资助金额:
    $ 30.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Glutamine Metabolism in Alveolar Macrophages following Influenza A Infection
甲型流感感染后肺泡巨噬细胞的谷氨酰胺代谢
  • 批准号:
    10607319
  • 财政年份:
    2023
  • 资助金额:
    $ 30.6万
  • 项目类别:
The function and regulation of tissue resident alveolar macrophages turnover by host and environmental factors during homeostasis and in infections
稳态和感染期间宿主和环境因素对组织驻留肺泡巨噬细胞周转的功能和调节
  • 批准号:
    471247
  • 财政年份:
    2022
  • 资助金额:
    $ 30.6万
  • 项目类别:
    Fellowship Programs
Using a Lung on Chip Device to Study Alveolar Macrophages as Intracellular Reservoirs for Staphylococcus aureus
使用肺芯片装置研究肺泡巨噬细胞作为金黄色葡萄球菌的细胞内储库
  • 批准号:
    485971
  • 财政年份:
    2022
  • 资助金额:
    $ 30.6万
  • 项目类别:
    Studentship Programs
Analysis of innate immune response of alveolar macrophages and epithelial-mesenchymal transition of alveolar epithelial cells
肺泡巨噬细胞的先天免疫反应和肺泡上皮细胞的上皮间质转化分析
  • 批准号:
    22K06698
  • 财政年份:
    2022
  • 资助金额:
    $ 30.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cholesterol crystal-mediated inflammation in alveolar macrophages: an emerging role inidiopathic lung fibrosis?
胆固醇晶体介导的肺泡巨噬细胞炎症:在特发性肺纤维化中的新兴作用?
  • 批准号:
    462596862
  • 财政年份:
    2021
  • 资助金额:
    $ 30.6万
  • 项目类别:
    WBP Position
Elucidation of idiopathic pneumonia syndrome: Angiotensin 2 activates alveolar macrophages
特发性肺炎综合征的阐明:血管紧张素 2 激活肺泡巨噬细胞
  • 批准号:
    21K16251
  • 财政年份:
    2021
  • 资助金额:
    $ 30.6万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Establishment of novel macrophage cell lines to study the pathogenesis of respiratory bacterial pathogens in lung alveolar macrophages
建立新型巨噬细胞系以研究肺泡巨噬细胞中呼吸道细菌病原体的发病机制
  • 批准号:
    NC/V001019/1
  • 财政年份:
    2021
  • 资助金额:
    $ 30.6万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了